Drug firm Lupin on Monday said it has launched Rufinamide Tablets, an anticonvulsant medication, in the American market.
The company has launched the product, a generic version of Eisai Inc's Banzel tablets, in 200 mg and 400 mg strengths, the drug firm said in a statement.
As per IQVIA data, Rufinamide tablets had estimated annual sales of $138 million in the U.S.
Shares of the company were trading 0.81% down at Rs 769.05 apiece on the BSE.
ADVERTISEMENT
RECOMMENDED FOR YOU
PM Modi To Participate In Massive International Yoga Day In Andhra Pradesh On June 21
Jun 21, 2025
Cognizant To Invest Rs 1,582 Crore For New Visakhapatnam Campus, Gets Land For 99 Paise
Jun 20, 2025
Redmi Pad 2 Tablet Launched In India: Check Price And Key Features
Jun 19, 2025
Planning To Buy Tablet In 2025: Top Picks From Apple, Samsung, Google And More
Jun 06, 2025
POPULAR
1
Prime Focus Shares Soar As Strategic DNEG Acquisition Fuels Rally
2
Shell's India Expansion Plan: Oil Giant Acquires Raj Petro Specialities
3
OYO-Owned European Holiday Home Brand DanCenter Plans To Add 250 Vacation Homes In India In FY26
4
Arijit Singh Becomes Most Followed Musician On Spotify, Beats Taylor Swift And Ed Sheeran
5